» Articles » PMID: 16682496

Maintenance of Viral Suppression in HIV-1-infected HLA-B*57+ Elite Suppressors Despite CTL Escape Mutations

Overview
Journal J Exp Med
Date 2006 May 10
PMID 16682496
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

Rare human immunodeficiency virus 1-infected individuals, termed elite suppressors (ES), maintain plasma virus levels of <50 copies/ml and normal CD4 counts without therapy. The major histocompatibility complex class I allele group human histocompatibility leukocyte antigen (HLA)-B*57 is overrepresented in this population. Mutations in HLA-B*57-restricted epitopes have been observed in ES, but their significance has remained unclear. Here we investigate the extent and impact of cytotoxic T lymphocyte (CTL) escape mutations in HLA-B*57+ ES. We provide the first direct evidence that most ES experience chronic low level viremia. Sequencing revealed a striking discordance between the genotypes of plasma virus and archived provirus in resting CD4+ T cells. Mutations in HLA-B*57-restricted Gag epitopes were present in all viruses from plasma but were rare in proviruses, suggesting powerful selective pressure acting at these epitopes. Surprisingly, strong CD8+ T cell interferon-gamma responses were detected against some mutant epitopes found in plasma virus, suggesting the development of de novo responses to viral variants. In some individuals, relative CD8+ T cell interleukin-2 responses showed better correlation with the selection observed in vivo. Thus, analysis of low level viremia reveals an unexpectedly high level of CTL escape mutations reflecting selective pressure acting at HLA-B*57-restricted epitopes in ES. Continued viral suppression probably reflects CTL responses against unmutated epitopes and residual or de novo responses against epitopes with escape mutations.

Citing Articles

HIV controllers: hope for a functional cure.

Deng Z, Yan H, Lambotte O, Moog C, Su B Front Immunol. 2025; 16:1540932.

PMID: 40070826 PMC: 11893560. DOI: 10.3389/fimmu.2025.1540932.


Distinguishable topology of the task-evoked functional genome networks in HIV-1 reservoirs.

Wisniewski J, Wiecek K, Ali H, Pyrc K, Kula-Pacurar A, Wagner M iScience. 2024; 27(11):111222.

PMID: 39559761 PMC: 11570469. DOI: 10.1016/j.isci.2024.111222.


HIV-1 controllers exhibit an enhanced antiretroviral innate state characterised by overexpression of p21 and MCPIP1 and silencing of ERVK-6 RNA expression.

de Azevedo S, Ribeiro-Alves M, Cortes F, Delatorre E, Hoagland B, Villela L Mem Inst Oswaldo Cruz. 2024; 119:e240071.

PMID: 39292108 PMC: 11404982. DOI: 10.1590/0074-02760240071.


NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control.

Sanchez-Gaona N, Gallego-Cortes A, Astorga-Gamaza A, Rallon N, Benito J, Ruiz-Mateos E JCI Insight. 2024; 9(20).

PMID: 39288262 PMC: 11529982. DOI: 10.1172/jci.insight.182660.


Exceptional, naturally occurring HIV-1 control: Insight into a functional cure.

Salgado M, Migueles S, Yu X, Martinez-Picado J Med. 2024; 5(9):1071-1082.

PMID: 39013460 PMC: 11411266. DOI: 10.1016/j.medj.2024.06.008.


References
1.
Sheehy A, Gaddis N, Choi J, Malim M . Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. DOI: 10.1038/nature00939. View

2.
Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, Siliciano J . Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol. 2004; 78(4):1718-29. PMC: 369469. DOI: 10.1128/jvi.78.4.1718-1729.2004. View

3.
Wherry E, Ahmed R . Memory CD8 T-cell differentiation during viral infection. J Virol. 2004; 78(11):5535-45. PMC: 415833. DOI: 10.1128/JVI.78.11.5535-5545.2004. View

4.
Price D, Goulder P, Klenerman P, Sewell A, Easterbrook P, Troop M . Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A. 1997; 94(5):1890-5. PMC: 20013. DOI: 10.1073/pnas.94.5.1890. View

5.
Cao Y, Qin L, Zhang L, Safrit J, Ho D . Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 1995; 332(4):201-8. DOI: 10.1056/NEJM199501263320401. View